Abstract-Subarachnoid hemorrhage (SAH) often induces a long-term narrowing of the cerebral artery called cerebral vasospasm. Myosin light chain (MLC) in the spastic basilar artery was reported previously to be phosphorylated by Ca 2ϩ /calmodulin-dependent MLC kinase. Because Rho-kinase, which is activated by the small GTPase Rho, phosphorylates not only MLC but also myosin phosphatase at its myosin-binding subunit (MBS), thus inactivating myosin phosphatase, we examined whether Rho-kinase is involved in the development of vasospasm. Cerebral vasospasm was produced in the canine basilar artery by a 2-hemorrhage method, and vasocontractions were induced by topical application of 80 mmol/L KCl or 0.5 mol/L serotonin to the canine basilar artery exposed transclivally. The phosphorylation of MLC in the basilar artery was increased concurrently with an enhancement in the intensity of vasospasm with the passage of time after SAH. In addition, Rho-kinase in the basilar artery was activated concurrently with an increase in the phosphorylation of MBS at Ser854 in vasospasm. The Rho-kinase activation levels in vasospasm on days 0 and 2 were comparable to those in KCl-and serotonin-induced sustained vasocontraction, respectively, and those in vasospasm on day 7 were markedly high. The topical application of Y-27632, a specific inhibitor of Rho-kinase, to the exposed spastic basilar artery on day 7 induced a dose-dependent dilation, and the intensities of vasospasm and the phosphorylation of MBS and MLC were simultaneously decreased by 10 mol/L Y-27632, although the decrease in MBS phosphorylation was more marked than the decrease in MLC phosphorylation. These results indicate that the activation of Rho-kinase and the phosphorylation of MLC and MBS occur concomitantly during vasospasm induced by SAH and suggest that Rho-kinase is involved in the enhancement of cerebral vasospasm in addition to Ca 2ϩ /calmodulin-dependent MLC kinase by increasing the phosphorylation of MLC directly or indirectly as a result of the inhibition of myosin phosphatase by its phosphorylation. 
T he management of patients with acutely ruptured intracranial aneurysms should achieve 2 major goals: (1) prevention of subsequent bleeding and (2) prevention and treatment of cerebral vasospasm, which usually develops between 4 and 14 days after subarachnoid hemorrhage (SAH). Despite the improvements in management of aneurysmal SAH, vasospasm remains an important cause of the morbidity and mortality accompanying this disease. 1 Recently, it has been reported that -calpain, but not m-calpain, in the canine basilar artery is continuously activated in vasospasm, 2, 3 indicating a continuous rise of intracellular Ca 2ϩ levels, because -and m-calpains are activated at 1 mol/L and 1 mmol/L Ca 2ϩ levels, respectively. 4 Myosin light chain (MLC) in the spastic canine basilar artery has been shown to be phosphorylated by Ca 2ϩ /calmodulin (CaM)-dependent MLC kinase, 5, 6 and the phosphorylation of MLC in the spastic anterior spinal artery is increased. 7 In addition, the phosphatase activity toward myosin in the basilar artery is decreased in vasospasm. 8 Because the use of a Ca 2ϩ indicator in experiments of smooth muscle contraction revealed that the force/Ca 2ϩ ratio in smooth muscle contraction is variable, the Ca 2ϩ /CaM-dependent MLC kinase pathway cannot solely account for the mechanisms of agonist-induced or GTP-␥-Sinduced increase in the force/Ca 2ϩ ratio, so-called Ca 2ϩ sensitization. 9 -14 Therefore, an additional mechanism that can regulate Ca 2ϩ sensitization of vascular smooth muscle has been considered. With the use of membrane permeabilization of smooth muscle, the possibility that monomeric Ras family G proteins, such as Rho, contribute to Ca 2ϩ sensitization of smooth muscle was demonstrated. 13, 15, 16 In permeabilized smooth muscle cells, GTP-␥-S induces MLC phosphorylation at submaximal Ca 2ϩ concentration by inhibiting the dephosphorylation of MLC, 10, 13 presumably by activating Rho. 17 Recently, Rho-kinase, which is activated by Rho, 16, 18, 19 has been reported to phosphorylate not only MLC stoichiometrically at the site that is phosphorylated by Ca 2ϩ /CaMdependent MLC kinase 20 but also myosin phosphatase at its myosin-binding subunit (MBS), thus inactivating it in vitro. 21 These findings in a cell-free system, plus the reports of G-protein-mediated Ca 2ϩ sensitization of smooth muscle contraction, 13, 14, 22, 23 suggest that Rho-kinase may induce contraction and concomitant MLC phosphorylation of the smooth muscle. 24, 25 In the present study, we examine whether Rho-kinase is involved in the development of cerebral vasospasm in the presence of elevated intracellular Ca 2ϩ levels.
Materials and Methods
Cerebral vasospasm was produced in dogs by an injection of 5 mL fresh autogenous arterial blood into the cisterna magna, followed by another injection 2 days later. Vasocontractions were induced by a topical application of 80 mmol/L KCl and 0.5 mol/L serotonin for 15 minutes (KCl-15 and serotonin-15 subgroups, respectively) or 90 minutes (KCl-90 and serotonin-90 subgroups, respectively) to the canine basilar artery exposed via a transclival route. Vasospasm and vasocontraction of the basilar artery were confirmed by angiography or by use of a surgical microscope. The animals were euthanized after a perfusion with 500 mL physiological salt solution, and the basilar artery was removed together with the brain. In the vasospasm group, the blood clot around the basilar artery and its branches was carefully removed without any mechanical stimulation given to the arteries. After it was washed briefly with physiological salt solution, the basilar artery was quickly frozen in liquid nitrogen until used. The phosphorylations of MLC and MBS in myosin phosphatase and the activity of Rho-kinase were studied. The phosphorylation of MLC was examined by urea-glycerol gel electrophoresis and immunoblot analysis with anti-MLC antibody, and phosphorylated MLC was expressed as a percentage of total MLC (ie, unphosphorylated MLC plus phosphorylated MLC). Rho-kinase activity was examined by Rho-kinase assay and immunoblot analysis with antiglutathione-S-transferase-bovine Rho-kinase antibody and calculated by dividing the densimetric values of Rho-kinase activity by those of the immunoreactive Rho-kinase level. The phosphorylation of MBS was probed separately with anti-pS854 antibody, which was prepared against the synthetic phosphopeptide pS854 (CREKRR phosphoS 854 TGVSF) as an antigen, and with anti-glutathione-Stransferase-MBS-COOH terminal antibody and calculated by dividing the densitometric values of the phosphorylation levels of MBS by those of the immunoreactive levels of MBS. Finally, after the basilar artery in vasospasm on day 7 was exposed transclivally, it was treated by a topical 30-minute application of successively increasing concentrations of Y-27632, a specific Rho-kinase inhibitor. At the end of experiment, 10 mmol/L EGTA was added, and the reduced diameter of the spastic basilar artery was expressed as a percentage of the relaxation induced by EGTA.
An expanded Materials and Methods section is available online at http://www.circresaha.org. 
Results

Caliber of the Basilar Artery
No significant angiographic narrowing of the basilar artery was shown before the animals in the control group were killed. The percentage of caliber reduction, as shown in Figure 1 , indicates the occurrence of vasospasm and the increase in its intensity with the lapse of time after SAH. The mean percent calibers in the KCl and serotonin groups decreased over a period of Ϸ45 minutes after treatment and then stabilized, as shown in Figure 2 .
Phosphorylation of MLC and Activation of Rho-Kinase Associated With Phosphorylation of MBS
Previously, we confirmed that MLC in the spastic basilar artery was phosphorylated by Ca 2ϩ /CaM-dependent MLC kinase but not by protein kinase C. 5, 6 Therefore, we examined by glycerol-urea gel electrophoresis and subsequent immunoblot analysis whether the phosphorylation of MLC was increased in vasospasm. As shown in Figure 3 , the monophosphorylation of MLC was increased with the passage of time in vasospasm. In addition, the Rho-kinase assay demonstrated a progressive increase in Rho-kinase activity in the basilar artery in vasospasm on days 0, 2, and 7, as shown in Figure 4A , but immunoreactive Rho-kinase levels were not changed ( Figure 4B ), demonstrating a significant increase in Rho-kinase activity in vasospasm with the lapse of time after SAH ( Figure 4E ). The Rho-kinase activities were increased slightly in the KCl-15 subgroup, moderately in the KCl-90 and serotonin-15 subgroups, and markedly in the serotonin-90 subgroup, as shown in Figure 4F . Thus, the Rhokinase activities in vasospasm on days 0 and 2 were comparable to those in the KCl-90 or serotonin-15 subgroup and in the serotonin-90 subgroup, respectively. One of the major sites of phosphorylation of MBS by Rho-kinase has been identified as Ser854, and the antibody that specifically recognizes MBS phosphorylated at Ser854 has been developed. 26 When MBS phosphorylation of myosin phosphatase was immunologically examined with use of an anti-pS854 antibody, the phosphorylation of MBS was shown to increase in vasospasm on days 0 and 2 and particularly on day 7 ( Figure 4C ), without any significant changes in the immunoreactive MBS level ( Figure 4D ), demonstrating a significant increase in MBS phosphorylation in vasospasm, particularly on day 7 ( Figure 4E ).
Dilation of Spastic Artery by Y-27632
Representative angiograms of the basilar artery in the spastic group on day 7 are shown in Figure 5 . The meanϮSEM diameter of the spastic basilar arteries on day 7 was reduced to 56Ϯ3% of the control caliber (Figure 1) . To define the involvement of Rho-kinase in the development of vasospasm, Y-27632, a specific inhibitor of Rho-kinase, 27 was topically applied to the exposed spastic basilar artery on day 7 to examine the responses of caliber as well as the phosphorylation of MBS and of MLC in the spastic basilar artery. Before the topical application of Y-27632, the blood clot around the exposed spastic basilar artery was carefully removed to avoid inducing significant changes in the caliber of the spastic artery. The exposed spastic basilar artery was dilated dosedependently by a topical application of 3ϫ10 Ϫ7 to 1ϫ10 Ϫ4 mol/L Y-27632, as shown in Figure 5 and the Table. Taking the relaxation induced by 10 mmol/L EGTA as 100%, the meanϮSEM ED 50 value of Y-27632 in 3 dogs was 2.25Ϯ 0.28 mol/L (Table) . The topical application of 10 mol/L Y-27632 to the spastic basilar artery on day 7 in 3 dogs induced 69.7Ϯ2.6% relaxation, as shown in the Table. In addition, MBS phosphorylation levels were decreased from 870Ϯ73.5% to 105Ϯ6.2% ( Figures 4C and 4E) , and MLC phosphorylation levels were decreased from 74.4Ϯ9.5% to 22.8Ϯ8.2% ( Figure 6 ). Thus, the extent of decrease in MLC phosphorylation after the topical application of 10 mol/L Y-27632 ( Figure 6 ) was consistent with that of dilatation of the exposed spastic basilar artery (Table) . The topical application of 10 mmol/L EGTA reduced MLC phosphorylation in vasospasm on day 7 from 74.4Ϯ9.5% to 0.5Ϯ0.2%, as shown in Figure 6 .
Discussion
The phosphorylation of MLC in the basilar artery examined by glycerol-urea gel electrophoresis and subsequent immunoblot analysis demonstrated an increase in vasospasm with the passage of time after SAH. At the same time, Rho-kinase was activated, and the phosphorylation of MBS was elevated in the basilar artery in vasospasm. Recently, Kimura et al 21 have shown that activated Rho-kinase phosphorylates MBS of myosin phosphatase, thereby leading to a decrease in myosin phosphatase activity in vitro. The decrease in activity of myosin phosphatase in the spastic basilar artery reported previously 8 is consistent with the present increase in MBS phosphorylation levels. It has been shown that MBS is phosphorylated and that myosin phosphatase activity is inactivated during the action of thromboxane A 2 in platelets, and both reactions are blocked by prior treatment of platelets with Clostridium botulinum C3 toxin, which interferes with Rho 
Ϫ5 mol/L (h), and 1ϫ10 Ϫ4 mol/L (i) and of 10 mmol/L EGTA ( j ).
Response of Exposed Basilar Artery to Topical Application of Y-27632 on Day 7
Relaxation After Y-27632, % functions. 28 Similar observations have been made in the endothelial cells responding to thrombin. 29 In addition, the activated Rho-kinase stoichiometrically phosphorylates MLC at the Ser19 residue, which is the site phosphorylated by Ca 2ϩ /CaM-dependent MLC kinase. 19 Thus, the activated Rho-kinase in vasospasm appears to induce MLC phosphorylation by the direct phosphorylation and/or inactivation of myosin phosphatase. It may be noted that the direct phosphorylation of MLC by Rho-kinase in smooth muscle remains to be elucidated, because GTP-␥-S induces minimal MLC phosphorylation in permeabilized smooth muscle in the presence of EGTA. 10, 15 Because the level of MBS phosphorylation in vasospasm on day 7 is much higher than that the level on day 2, Rho-kinase may play more critical roles at the later stage in vasospasm.
The topical application of 10 mol/L Y-27632 to the spastic basilar artery on day 7 induced a concurrent decrease in contraction and phosphorylation of MBS and MLC. Y-27632 is a specific inhibitor of Rho-kinase and selectively inhibits agonist (including serotonin)-induced smooth muscle contraction by inhibiting Ca 2ϩ sensitization (K i 0.14 for Rho-kinase, K i 26 for protein kinase C, and K i Ͼ250 for MLC kinase). 27 The concentration of Y-27632 used in the present study inhibits GTP-␥-S-induced contraction of permeabilized strips of rabbit mesentery artery by Ϸ80% and phenylephrine-induced contraction of rabbit aortic strips by Ϸ90% but has little effect on Ca 2ϩ -induced and calyculin A-induced contraction of permeabilized strips of rabbit mesentery artery. 27 Rho-kinase inhibition by Y-27632 in vasospasm has demonstrated that MBS phosphorylation is more decreased than is MLC phosphorylation and that the MLC phosphorylation induced by Ca 2ϩ /CaM-dependent MLC kinase in vasospasm because of the continuous elevation of intracellular Ca 2ϩ levels 2,3 may not be affected by Y-27632. Therefore, the Y-27632-specific MLC phosphorylation in vasospasm may be mediated by Rho-kinase mainly through the inhibition of myosin phosphatase. 21 Thus, although the intracellular Ca 2ϩ level is elevated in vasospasm, 2,3 the activation of Rho-kinase associated with the elevation of MBS phosphorylation and the Y-27632-sensitive MLC phosphorylation in the spastic basilar artery suggests the involvement of Rho-kinase in the enhancement of vasospasm, namely, a Ca 2ϩ sensitization mechanism. 9, 14, 21, 23, 30 The present study (together with the previous studies) indicates that the Rho-Rho-kinase pathway is activated during the development of cerebral vasospasm. How is the Rho-Rho-kinase pathway activated? Several recent studies imply that some trimeric G-protein-coupled receptors, including lysophosphatidic acid, thrombin, and serotonin receptors, are linked to the Rho-Rho-kinase pathway. 31 The ␣ subunits from G i , G q , G 12 , and G 13 are postulated to activate Rho by regulating GDP/GTP exchange factors (GEFs) for Rho. [32] [33] [34] [35] For G ␣13 , a direct interaction with a specific Rho-GEF, p115-RhoGEF, is known to enhance exchange activity and Rho-GTP binding. 34, 35 Although the mechanism by which SAH activates the Rho-Rho-kinase pathway remains to be clarified, it is tempting to speculate that certain ligands for the G-protein-coupled receptors, which are produced after SAH, activate Rho (and subsequently Rho-kinase) and enhance cerebral vasospasm. The activation of the tyrosine kinase pathway in vasospasm 6 suggests an involvement of G-protein-coupled receptors in addition to receptor protein tyrosine kinase. The monophosphorylation of MLC in the spastic basilar artery on day 7 was almost completely inhibited by the topical application of 10 mmol/L EGTA. Because the concentration of EGTA used in the present study induces cytosolic Ca 2ϩ levels to nominally zero, 31 Ca 2ϩ /CaMdependent MLC kinase in the spastic basilar artery on day 7 could be almost completely inactivated when EGTA was applied topically. In contrast, because Rho-kinase is theoretically insensitive to 10 mmol/L EGTA, Rho-kinase in the spastic basilar artery on day 7, after topical application of EGTA, would be still capable of phosphorylating not only MLC 20 but also myosin phosphatase, thus inactivating it. 21 Therefore, the nominally zero phosphorylation of MLC in the spastic basilar artery on day 7 induced by the topical application of EGTA would be mediated mainly by the complete inhibition of Ca 2ϩ /CaM-dependent MLC kinase, although we could not rule out the possibility that Rho-kinase activity is inhibited under the conditions.
The intracellular Ca 2ϩ levels in the canine basilar artery were transiently elevated only at the beginning of serotonininduced contraction. 2, 3 Therefore, serotonin-induced contraction is mainly dependent on the activation of Rho-kinase, according to the evidence of marked relaxation of serotonininduced smooth muscle contraction by Y-27632. 27 In contrast, the intracellular Ca 2ϩ levels in the spastic basilar artery are continuously increased according to the evidence of -calpain activation, 2,3 and the MLC phosphorylation in the spastic basilar artery is reported to be mediated by Ca 2ϩ /CaMdependent MLC kinase. 5, 6 However, the maximum response of the spastic basilar artery to ML-9, a selective inhibitor of Ca 2ϩ /CaM-dependent MLC kinase, was less than that to EGTA, 5 suggesting that mechanisms other than the participation of Ca 2ϩ /CaM-dependent MLC kinase (eg, involvement of Rho-kinase) operate in vasospasm. Therefore, the present study suggests that Rho-kinase works synergistically with Ca 2ϩ /CaM-dependent MLC kinase in vasospasm and that the vascular smooth muscle cells need such a 2-pronged approach on MLC phosphorylation to sustain the uninterrupted increase in cellular contractility characteristic of vasospasm. It remains to be determined to what extent Rho-kinase and Ca 2ϩ /CaM-dependent MLC kinase are involved in the development of vasospasm and to detect other mechanisms responsible for the development of vasospasm. However, from the therapeutic point of view, it is noted that the topical application of EGTA to the spastic basilar artery demonstrates the maximal relaxation compared with other reagents, such as inhibitors of Rho-kinase or Ca 2ϩ /CaM-dependent MLC kinase.
